DE69405251D1 - Methoden zur diagnose von allergie und prüfung anti-allergischer therapeutika - Google Patents
Methoden zur diagnose von allergie und prüfung anti-allergischer therapeutikaInfo
- Publication number
- DE69405251D1 DE69405251D1 DE69405251T DE69405251T DE69405251D1 DE 69405251 D1 DE69405251 D1 DE 69405251D1 DE 69405251 T DE69405251 T DE 69405251T DE 69405251 T DE69405251 T DE 69405251T DE 69405251 D1 DE69405251 D1 DE 69405251D1
- Authority
- DE
- Germany
- Prior art keywords
- patient serum
- allergen
- pct
- host cells
- ige
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
- G01N33/6857—Antibody fragments
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16543693A | 1993-12-10 | 1993-12-10 | |
PCT/US1994/014282 WO1995016203A2 (en) | 1993-12-10 | 1994-12-09 | Methods for diagnosis of allergy and screening of anti-allergy therapeutics |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69405251D1 true DE69405251D1 (de) | 1997-10-02 |
DE69405251T2 DE69405251T2 (de) | 1998-02-05 |
Family
ID=22598886
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69405251T Expired - Lifetime DE69405251T2 (de) | 1993-12-10 | 1994-12-09 | Methoden zur diagnose von allergie und prüfung anti-allergischer therapeutika |
Country Status (10)
Country | Link |
---|---|
US (1) | US5714338A (de) |
EP (1) | EP0733207B1 (de) |
JP (1) | JP3507852B2 (de) |
AT (1) | ATE157455T1 (de) |
CA (1) | CA2176811C (de) |
DE (1) | DE69405251T2 (de) |
DK (1) | DK0733207T3 (de) |
ES (1) | ES2108566T3 (de) |
GR (1) | GR3025089T3 (de) |
WO (1) | WO1995016203A2 (de) |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9526599D0 (en) * | 1995-12-28 | 1996-02-28 | Sandoz Ltd | Elisa test system |
DE19643427C1 (de) * | 1996-10-22 | 1998-02-12 | Bundesrep Deutschland | Verfahren zur Bestimmung von Allergenen in der Luft |
US6165799A (en) * | 1996-12-10 | 2000-12-26 | Heska Corporation | Detection of anti-Fc.sub.ε R autoantibodies in asthmatics |
US7122636B1 (en) | 1997-02-21 | 2006-10-17 | Genentech, Inc. | Antibody fragment-polymer conjugates and uses of same |
US6060326A (en) * | 1997-04-07 | 2000-05-09 | Heska Corporation | Method to detect canine IgE and kit therefor |
FR2765341A1 (fr) * | 1997-06-25 | 1998-12-31 | Alain Funes | Methode pour l'analyse de l'activation des basophiles humains par mesure de l'expression membranaire du marqueur cd63 |
AU1727500A (en) * | 1998-11-17 | 2000-06-05 | Tanox, Inc. | Bispecific molecules cross-linking itim and itam for therapy |
AU2001234419A1 (en) * | 2000-01-14 | 2001-07-24 | Tanox, Inc. | Administering ige antagonists during pregnancy to ameliorate allergic diseases in the offspring |
US6889145B1 (en) | 2000-03-15 | 2005-05-03 | Northwestern University | Three-dimensional model of a Fc region of an IgE antibody and uses thereof |
EP1195606A1 (de) * | 2000-10-03 | 2002-04-10 | VBC-Genomics Forschungsges.m.b.H. | Allergen-Assay auf Basis von Mikroanordnungen |
DE10110838C2 (de) * | 2001-03-06 | 2003-04-03 | Mlu Halle Wittenberg | Verfahren zur Diagnostik von Allergien, Pseudoallergien und Intoleranzen |
FR2831186B1 (fr) * | 2001-10-22 | 2004-06-18 | Aventis Pharma Sa | Production d'heparine a partir de cultures de mastocytes |
US6870034B2 (en) | 2002-02-05 | 2005-03-22 | Genentech, Inc. | Protein purification |
JP4319979B2 (ja) | 2002-04-26 | 2009-08-26 | ジェネンテック・インコーポレーテッド | タンパク質の非アフィニティ精製 |
HUE050171T2 (hu) | 2003-07-28 | 2020-11-30 | Genentech Inc | Protein-A kioldódásának csökkentése protein-A affinitáskromatográfia során |
US7613619B1 (en) * | 2004-03-30 | 2009-11-03 | Harter Michael R | Method for identifying allergens and other influencing agents that may cause a reaction |
US7655229B2 (en) * | 2004-09-02 | 2010-02-02 | Chan Andrew C | Anti-FC-gamma RIIB receptor antibody and uses therefor |
WO2006028956A2 (en) * | 2004-09-02 | 2006-03-16 | Genentech, Inc. | Anti-fc-gamma riib receptor antibody and uses therefor |
US7662926B2 (en) * | 2004-09-02 | 2010-02-16 | Genentech, Inc. | Anti-Fc-gamma receptor antibodies, bispecific variants and uses therefor |
JO3000B1 (ar) | 2004-10-20 | 2016-09-05 | Genentech Inc | مركبات أجسام مضادة . |
ATE505728T1 (de) * | 2005-03-16 | 2011-04-15 | Nutricia Nv | Verfahren zur bestimmung einer allergischen reaktion |
US20070117217A1 (en) * | 2005-06-16 | 2007-05-24 | The Regents Of The University Of California | Large scale parallel immuno-based allergy test and device for evanescent field excitation of fluorescence |
US20080011058A1 (en) * | 2006-03-20 | 2008-01-17 | The Regents Of The University Of California | Piezoresistive cantilever based nanoflow and viscosity sensor for microchannels |
FR2902799B1 (fr) | 2006-06-27 | 2012-10-26 | Millipore Corp | Procede et unite de preparation d'un echantillon pour l'analyse microbiologique d'un liquide |
WO2008064684A1 (en) * | 2006-12-01 | 2008-06-05 | Statens Serum Institut | Screening method using sample adsorption on filter paper |
US8569464B2 (en) | 2006-12-21 | 2013-10-29 | Emd Millipore Corporation | Purification of proteins |
WO2008079280A1 (en) | 2006-12-21 | 2008-07-03 | Millipore Corporation | Purification of proteins |
US8362217B2 (en) | 2006-12-21 | 2013-01-29 | Emd Millipore Corporation | Purification of proteins |
WO2008091740A2 (en) | 2007-01-22 | 2008-07-31 | Genentech, Inc. | Polyelectrolyte precipitation and purification of antibodies |
US8191403B2 (en) * | 2007-03-27 | 2012-06-05 | Richmond Chemical Corporation | Petroleum viscosity measurement and communication system and method |
EP2188302B1 (de) | 2007-07-09 | 2017-11-01 | Genentech, Inc. | Verhinderung der reduktion der disulfidbindung während der rekombinanten herstellung von polypeptiden |
EP2840090B1 (de) | 2007-10-30 | 2018-02-21 | Genentech, Inc. | Antikörperaufreinigung durch Kationen-Austausch-Chromatographie |
US8999702B2 (en) * | 2008-06-11 | 2015-04-07 | Emd Millipore Corporation | Stirred tank bioreactor |
AU2008360625C1 (en) | 2008-08-14 | 2017-01-19 | Genentech, Inc. | Methods for removing a contaminant using indigenous protein displacement ion exchange membrane chromatography |
EP2684570A1 (de) | 2008-09-10 | 2014-01-15 | F. Hoffmann-La Roche AG | Zusammensetzungen und Verfahren zur Prävention des oxidativen Abbaus von Proteinen |
US20110020327A1 (en) * | 2008-12-16 | 2011-01-27 | Millipore Corporation | Purification of proteins |
SG171446A1 (en) | 2008-12-16 | 2011-07-28 | Millipore Corp | Stirred tank reactor and method |
SG173812A1 (en) | 2009-02-27 | 2011-09-29 | Genentech Inc | Methods and compositions for protein labelling |
US10184937B2 (en) * | 2009-03-31 | 2019-01-22 | United Arab Emirates University | Minimally invasive assessment of IgE mediated allergy |
DE102009030845A1 (de) * | 2009-06-26 | 2010-12-30 | Siemens Aktiengesellschaft | Verfahren und Kit zur Diagnose oder Prognose einer Kontrastmittelallergie |
CN104059955A (zh) | 2009-08-11 | 2014-09-24 | 弗·哈夫曼-拉罗切有限公司 | 在无谷氨酰胺的细胞培养基中的蛋白质生产 |
RU2571929C2 (ru) | 2009-09-01 | 2015-12-27 | Дженентек, Инк. | Улучшенная очистка белка посредством модифицированного элюирования белка а |
KR102218495B1 (ko) | 2010-03-22 | 2021-02-19 | 제넨테크, 인크. | 단백질-함유 제제의 안정화에 유용한 조성물 및 방법 |
BR112012027828A2 (pt) | 2010-05-03 | 2016-08-09 | Genentech Inc | composição de matéria, artigo de fabricação e método de redução da viscosidade de uma formulação contendo proteína e de preparação de uma formulação aquosa contendo proteína |
SG10201804385YA (en) | 2010-05-17 | 2018-06-28 | Emd Millipore Corp | Stimulus responsive polymers for the purification of biomolecules |
HUE030820T2 (en) | 2010-05-28 | 2017-06-28 | Hoffmann La Roche | Decreasing Lactate Levels and Enhancing Polypeptide Production by Control of Lactate Dehydrogenase and Pyruvate Dehydrogenase Kinase Expression |
WO2011163458A2 (en) | 2010-06-24 | 2011-12-29 | Genentech, Inc. | Compositions and methods for stabilizing protein-containing formulations |
CN103154032A (zh) | 2010-08-13 | 2013-06-12 | 弗·哈夫曼-拉罗切有限公司 | 用于疾病治疗的针对IL-1β和IL-18的抗体 |
WO2012030512A1 (en) | 2010-09-03 | 2012-03-08 | Percivia Llc. | Flow-through protein purification process |
ES2809211T3 (es) | 2011-07-08 | 2021-03-03 | Emd Millipore Corp | Filtros de profundidad mejorados para procesos biotecnológicos desechables |
BR112014015101A8 (pt) | 2011-12-22 | 2021-06-08 | Genentech Inc | métodos para intensificar eficiência de etapas de cromatografia a jusante para purificação de anticorpos |
CN104350156B (zh) | 2012-03-27 | 2019-04-02 | 弗·哈夫曼-拉罗切有限公司 | 用于重组蛋白质的改进的收获操作 |
RU2711089C2 (ru) | 2012-05-18 | 2020-01-15 | Дженентек, Инк. | Высококонцентрированные составы моноклональных антител |
EP2934602B1 (de) | 2012-12-19 | 2019-02-27 | Genentech, Inc. | Verfahren und zusammensetzungen zur radiohalogen proteinmarkierung |
KR102355306B1 (ko) | 2014-07-09 | 2022-01-24 | 제넨테크, 인크. | 세포 은행의 해동 회수를 개선하는 ph 조정 |
AU2017242031B2 (en) | 2016-03-29 | 2023-07-27 | Geltor, Inc. | Expression of proteins in gram-negative bacteria wherein the ratio of periplasmic volume to cytoplasmic volume is between 0.5:1 and 10:1 |
KR102579836B1 (ko) | 2016-12-22 | 2023-09-15 | 제넨테크, 인크. | 동결건조된 폴리펩타이드의 재구성 시간을 감소시키기 위한 방법 및 제제 |
US11180541B2 (en) | 2017-09-28 | 2021-11-23 | Geltor, Inc. | Recombinant collagen and elastin molecules and uses thereof |
EA202092904A1 (ru) | 2018-07-03 | 2021-04-22 | Бристол-Маерс Сквибб Компани | Способы получения рекомбинантных белков |
US20210380923A1 (en) | 2018-10-10 | 2021-12-09 | Boehringer Ingelheim International Gmbh | Method for membrane gas transfer in high density bioreactor culture |
WO2020205716A1 (en) | 2019-04-01 | 2020-10-08 | Genentech, Inc. | Compositions and methods for stabilizing protein-containing formulations |
EP3953380A4 (de) | 2019-04-12 | 2023-01-25 | Geltor, Inc. | Rekombinantes elastin und herstellung davon |
JP2022543781A (ja) | 2019-08-01 | 2022-10-14 | ブリストル-マイヤーズ スクイブ カンパニー | フェッドバッチ細胞培養におけるタンパク質産生性の改良方法 |
US20230357815A1 (en) | 2020-09-22 | 2023-11-09 | Bristol-Myers Squibb Company | Methods for increasing productivity of therapeutic proteins |
CN113495139A (zh) * | 2021-07-07 | 2021-10-12 | 上海清芮科技有限公司 | 一种宠物特应性体质的检测方法 |
WO2023015234A1 (en) | 2021-08-05 | 2023-02-09 | Bristol-Myers Squibb Company | Cell culture methods for producing therapeutic proteins |
WO2023049687A1 (en) | 2021-09-21 | 2023-03-30 | Bristol-Myers Squibb Company | Methods of controlling the level of dissolved oxygen (do) in a solution comprising a recombinant protein in a storage container |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4559310A (en) * | 1983-05-20 | 1985-12-17 | Dana Farber Cancer Institute | Assay methods and systems utilizing mast cell clones |
US4946788A (en) * | 1985-06-11 | 1990-08-07 | Ciba-Geigy Corporation | Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, processes and applications |
DE3777245D1 (de) * | 1986-04-30 | 1992-04-16 | Junji Yodoi | Protein und verfahren zu dessen herstellung. |
US5180805A (en) * | 1986-07-02 | 1993-01-19 | Research Corporation Limited | Polypeptide competitor for immunoglobulin E |
GB8727045D0 (en) * | 1987-11-19 | 1987-12-23 | Research Corp Ltd | Immunoglobulin e competitor |
US4962035A (en) * | 1987-12-01 | 1990-10-09 | President And Fellows Of Harvard College | DNA encoding IgE receptor alpha-subunit or fragment thereof |
JPH03127997A (ja) * | 1989-10-11 | 1991-05-31 | Kuraray Co Ltd | ヒト1gE結合因子に特異的なモノクローン抗体、それを産生するハイブリドーマおよびその用途 |
CA2059842A1 (en) * | 1991-02-11 | 1992-08-12 | Richard A. Chizzonite | Ige-receptor-antibodies |
AU2917992A (en) * | 1991-12-05 | 1993-06-28 | Board Of Regents Of The University Of Nebraska, The | Allergen specific immunoglobulin-e producer test for diagnosing allergies |
GB9224956D0 (en) * | 1992-11-28 | 1993-01-20 | Euro Dpc Ltd | Improvements relating to allergen testing & apparatus |
-
1994
- 1994-12-09 AT AT95905357T patent/ATE157455T1/de active
- 1994-12-09 JP JP51638795A patent/JP3507852B2/ja not_active Expired - Lifetime
- 1994-12-09 US US08/393,014 patent/US5714338A/en not_active Expired - Lifetime
- 1994-12-09 DE DE69405251T patent/DE69405251T2/de not_active Expired - Lifetime
- 1994-12-09 DK DK95905357.0T patent/DK0733207T3/da active
- 1994-12-09 CA CA002176811A patent/CA2176811C/en not_active Expired - Lifetime
- 1994-12-09 ES ES95905357T patent/ES2108566T3/es not_active Expired - Lifetime
- 1994-12-09 EP EP95905357A patent/EP0733207B1/de not_active Expired - Lifetime
- 1994-12-09 WO PCT/US1994/014282 patent/WO1995016203A2/en active IP Right Grant
-
1997
- 1997-10-20 GR GR970402730T patent/GR3025089T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
WO1995016203A3 (en) | 1995-06-29 |
EP0733207B1 (de) | 1997-08-27 |
CA2176811C (en) | 2008-01-29 |
EP0733207A1 (de) | 1996-09-25 |
JPH09506435A (ja) | 1997-06-24 |
DK0733207T3 (da) | 1998-04-20 |
ES2108566T3 (es) | 1997-12-16 |
JP3507852B2 (ja) | 2004-03-15 |
US5714338A (en) | 1998-02-03 |
CA2176811A1 (en) | 1995-06-15 |
GR3025089T3 (en) | 1998-01-30 |
WO1995016203A2 (en) | 1995-06-15 |
DE69405251T2 (de) | 1998-02-05 |
ATE157455T1 (de) | 1997-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69405251T2 (de) | Methoden zur diagnose von allergie und prüfung anti-allergischer therapeutika | |
Cox et al. | Measurement of cytokine release at the single cell level using the ELISPOT assay | |
Chowdhury et al. | Validation and comparison of two multiplex technologies, Luminex® and Mesoscale Discovery, for human cytokine profiling | |
Popple et al. | The lymphocyte transformation test in allergic contact dermatitis: new opportunities | |
De Rosa et al. | OMIP-014: Validated multi-functional characterization of antigen-specific human T-cells by intracellular cytokine staining | |
BRPI0411059A (pt) | tiras de teste diagnóstico para detecção de um analito de interesse em uma amostra lìquida, para detecção de anticorpo de anti-hiv em uma amostra, e de teste de gravidez de imuno-diagnóstico, e, método de detecção de um anticorpo de interesse em uma amostra lìquida | |
Suthumchai et al. | The measurement of drug‐induced interferon γ‐releasing cells and lymphocyte proliferation in severe cutaneous adverse reactions | |
CN105954521B (zh) | 一种结核分枝杆菌感染诊断试剂盒 | |
Sherman et al. | CD4+ T cell enumeration in HIV infection with limited resources | |
Tanaka et al. | Multiparameter flow cytometric approach for simultaneous evaluation of proliferation and cytokine‐secreting activity in T cells responding to allo‐stimulation | |
CN205353099U (zh) | 一种省时高效的免疫层析多联检测卡 | |
Nicoll et al. | The public health applications of unlinked anonymous seroprevalence monitoring for HIV in the United Kingdom | |
Choquet-Kastylevsky et al. | Drug allergy diagnosis in humans: possibilities and pitfalls | |
ATE147410T1 (de) | Igm-antikörper gegen protamin | |
Lushington et al. | Are counseling students stressed? A cross-cultural comparison of burnout in Australian, Singaporean and Hong Kong counseling students | |
Wolanczyk-Medrala et al. | CD164 as a basophil activation marker | |
Gujar et al. | Flow cytometric quantification of T cell proliferation and division kinetics in woodchuck model of hepatitis B | |
Smits et al. | Evaluating the response of patients undergoing both allergy skin testing and in vitro allergy testing with the ImmunoCAP Technology System | |
Granade | Use of rapid HIV antibody testing for controlling the HIV pandemic | |
Chirumbolo | CD164 and other recently discovered activation markers as promising tools for allergy diagnosis: what’s new? | |
SE9501782D0 (sv) | Method of predicting the therapeutic response of a drug against a malignant tumour | |
Liu et al. | Fibronectin EIIIA splicing variant: a useful contribution to forensic wounding interval estimation | |
Dunsterville et al. | The use of dual-Cell-Tracker dye staining for the identification and characterization of peanut-specific T-cell subsets | |
Flores-Valdez | Uncovering the hidden: complexity and strategies for diagnosing latent tuberculosis | |
Lin et al. | Luciferase Immunoprecipitation Systems immunoassay is a sensitive, rapid method to detect allergen component-specific IgE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |